Buyer-specific product requirements
The program begins with the required molecule, dosage form, strength, batch size, quality profile and destination-market expectations.
Manufacturing coordination
Neutral-Code Pharmaceutical Manufacturing
KOIT coordinates neutral-code manufacturing programs with suitable pharmaceutical manufacturing partners, aligning buyer-specific product, packaging, documentation and market requirements without acting as the manufacturer or approval authority.
The model
What is neutral-code manufacturing?
It is a buyer-led pharmaceutical manufacturing and supply structure built around agreed specifications, controlled information flows and destination-market requirements. It can support commercial confidentiality, but never at the expense of required regulatory transparency.
Agreed manufacturing specifications
Product and quality specifications are reviewed with the proposed manufacturing partner before commercial terms and supply arrangements are finalized.
Packaging and labelling alignment
Primary packs, secondary packs, artwork, language and labelling needs are coordinated subject to technical feasibility and applicable local rules.
Confidential commercial structures
Information flows and supply relationships can be structured with appropriate confidentiality while preserving the documentation required by responsible parties and authorities.
Where a conventional own-label model is more suitable, KOIT can also coordinate a broader pharmaceutical contract manufacturing program.
KOIT’s role
Coordination from requirement to supply
KOIT acts as the international business-development and coordination partner. Manufacturing, regulatory decisions and approvals remain with the appropriately qualified organizations and authorities.
Requirement assessment
Clarify the product, intended market, expected volume, pack configuration, documentation needs and commercial priorities.
Manufacturer identification
Identify suitable manufacturing capabilities and coordinate initial technical and commercial evaluation with qualified counterparties.
GMP documentation review
Coordinate available site, quality and product documents for review by the buyer, local partner and relevant regulatory professionals.
Product and packaging coordination
Align specifications, presentations, artwork responsibilities, labelling inputs and supply documentation across the parties involved.
Commercial and regulatory coordination
Support discussions on quantities, timelines and supply structure while coordinating regulatory inputs with the responsible local parties.
International applications
Structured for the market the product must serve
Neutral-code manufacturing is not a single template. The product, manufacturing site, documents, packaging and supply model must be evaluated against the buyer’s needs and the destination market’s current requirements.
Latin America
Programs may support pharmaceutical companies and import partners seeking a suitable manufacturing base for market-specific products, packs and documentation, subject to each country’s requirements.
Southeast Asia
Neutral-code arrangements can help align regional commercial needs with qualified manufacturing capacity while local import, registration and labelling obligations remain fully applicable.
Africa
KOIT can coordinate product and manufacturer evaluation for private, institutional and distribution-led requirements where the proposed structure is commercially and regulatorily appropriate.
Other international markets
Each opportunity is assessed individually against product specifications, manufacturer capability, commercial viability and the destination market’s current rules.
Regulatory considerations
Confidentiality does not replace compliance
A neutral-code commercial structure does not bypass product registration, import requirements, labelling rules, manufacturer disclosure obligations or any other local regulatory requirement. Information required by the buyer, importer, registration holder, healthcare institution or competent authority must remain available through the appropriate process.
KOIT coordinates the relevant parties and available documentation but does not grant approvals or determine legal eligibility. Learn more about our product registration and regulatory coordination.
Who we work with
For partners building reliable pharmaceutical supply
Engagements are assessed against the product, market, documentation, volume and commercial structure required by each partner.
Pharmaceutical companies
Importers and distributors
Institutional buyers
Procurement partners
Healthcare supply-chain businesses
Process
A clear path from requirement to follow-up
- 01
Requirement Assessment
Define the product, specifications, pack, quantity, target market and documentary expectations.
- 02
Manufacturer Identification
Identify potential manufacturing partners whose capabilities fit the proposed program.
- 03
Specification Review
Review technical, quality, packaging and labelling requirements with the relevant parties.
- 04
Documentation and Commercial Coordination
Align available documents, responsibilities, quantities, timelines and commercial structure.
- 05
Supply Follow-Up
Coordinate communication through production planning, documentation and agreed supply milestones.
Where manufacturers and buyers operate across different jurisdictions, the program may also be evaluated alongside an appropriate Merchant Trade Transaction structure.
FAQ
Questions about neutral-code manufacturing
What is neutral-code pharmaceutical manufacturing?+
Neutral-code pharmaceutical manufacturing is a coordinated supply arrangement in which a product is manufactured to agreed buyer and market specifications under a defined commercial and confidentiality structure. The exact documentation, disclosure, packaging and labelling requirements depend on the product, parties and destination market.
How is neutral-code manufacturing different from contract manufacturing?+
Both involve a third-party manufacturer producing to agreed specifications. A neutral-code arrangement places additional emphasis on how the manufacturing source, commercial relationship and outward-facing supply information are managed. It does not remove any disclosure that regulators, importers or other responsible parties are legally required to receive.
What manufacturer documentation can be reviewed?+
Depending on the program and what the manufacturer can provide, review may include GMP evidence, site information, product specifications, certificates, dossier materials and other quality or registration documents. KOIT coordinates their exchange; the buyer and relevant regulatory professionals remain responsible for acceptance and use.
Does neutral-code manufacturing avoid product registration or import requirements?+
No. Neutral-code manufacturing does not bypass product registration, import authorization, establishment licensing, customs requirements or other local obligations. The applicable route must be determined for the product and destination market by the responsible local parties and authorities.
Can packaging and labelling be customized for the buyer?+
Buyer-specific pack formats, artwork and labelling can be evaluated with the proposed manufacturer. Feasibility depends on the product, batch size, manufacturing capability and the labelling and registration rules that apply in the destination market.
Can KOIT coordinate neutral-code manufacturing for international supply?+
KOIT can assess opportunities across Latin America, Southeast Asia, Africa and other international markets. Support depends on a suitable manufacturer, viable commercial terms, qualified local counterparties and a compliant regulatory and import pathway for the destination.
Discuss your requirement
Structure a neutral-code manufacturing program with KOIT.
Share the product, specifications, pack, expected volume and target market. KOIT will assess suitable manufacturing and coordination options for the requirement.